Rialto Wealth Management »

Esperion Therapeutics shares owned by Rialto Wealth Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Rialto Wealth Management from 13F filings

Historical chart of Rialto Wealth Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Rialto Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Rialto Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9k 593 3.16
2026-03-31 $1.6k 593 2.74
2025-12-31 $2.2k 593 3.70
2025-09-30 $1.6k 593 2.65
2025-06-30 $583 593 0.98
2025-03-31 $427 296 1.44

More positions owned by Rialto Wealth Management

Spdr Series Trust ST STR PR SP1500 (SPTM)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Vanguard Instl Index 0 3 Mo Tr Bi Etf (VBIL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
American Centy Etf Tr Avan Us Valu Etf (AVMV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Cre U S Reit Etf (USRT)

View all positions for Rialto Wealth Management

Top funds holding Esperion Therapeutics

Glazer Capital
BlackRock
Vanguard Capital Management
Goldman Sachs Group
State Street Corporation
Two Sigma Investments
Geode Capital Management
CNH Partners
Oddo Bhf Asset Management Sas
Balyasny Asset Management
FMR
Beryl Capital Management
PenderFund Capital Management
UBS Group
Alliancebernstein

View all funds holding Esperion Therapeutics